A mechanism of virulence:: Virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis

被引:202
作者
Chen, Minjian
Gan, Huixian
Remold, Heinz G.
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol,Dept Med,Med Res Ctr, Boston, MA 02115 USA
[2] Guangxi Med Univ, Affiliated Hosp 1, Clin Res Ctr, Nanning 530021, Guangxi, Peoples R China
关键词
D O I
10.4049/jimmunol.176.6.3707
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infection of human monocyte-derived macrophages with Mycobacterium tuberculosis at low multiplicities of infection leads 48-72 h after the infection to cell death with the characteristics of apoptosis or necrosis. Predominant induction of one or the other cell death modality depends on differences in mitochondrial membrane perturbation induced by attenuated and virulent strains. Infection of macrophages with the attenuated H37Ra or the virulent H37Rv causes mitochondrial outer membrane permeabilization characterized by cytochrome c release from the mitochondrial intermembrane space and apoptosis. Mitochondrial outer membrane permeabilization is transient, peaks 6 h after infection, and requires Ca2+ flux and B cell chronic lymphocytic leukemia/lymphoma 2-associated protein X translocation into mitochondria. In contrast, only the virulent H37Rv induces significant mitochondrial transmembrane potential (Delta psi(m)) loss caused by mitochondrial permeability transition. Dissipation of Delta psi(m) also peaks at 6 h after infection, is transient, is inhibited by the classical mitochondrial permeability transition inhibitor cyclosporine A, has a requirement for mitochondrial Ca2+ loading, and is independent of B cell chronic lymphocytic leukemia/lymphoma translocation into the mitochondria. Transient dissipation of 6 h after infection is essential for the induction of macrophage necrosis by Mtb, a mechanism that allows further dissemination of the pathogen and development of the disease.
引用
收藏
页码:3707 / 3716
页数:10
相关论文
共 47 条
  • [21] Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages
    Keane, J
    Remold, HG
    Kornfeld, H
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (04) : 2016 - 2020
  • [22] Keij JF, 2000, CYTOMETRY, V39, P203, DOI 10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO
  • [23] 2-Z
  • [24] Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c
    Korsmeyer, SJ
    Wei, MC
    Saito, M
    Weller, S
    Oh, KJ
    Schlesinger, PH
    [J]. CELL DEATH AND DIFFERENTIATION, 2000, 7 (12) : 1166 - 1173
  • [25] The mitochondrial death/life regulator in apoptosis and necrosis
    Kroemer, G
    Dallaporta, B
    Resche-Rigon, M
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1998, 60 : 619 - 642
  • [26] Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice
    Leemans, JC
    Juffermans, NP
    Florquin, S
    van Rooijen, N
    Vervoordeldonk, MJ
    Verbon, A
    van Deventer, SJH
    van der Poll, T
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (07) : 4604 - 4611
  • [27] Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
    Li, HL
    Zhu, H
    Xu, CJ
    Yuan, JY
    [J]. CELL, 1998, 94 (04) : 491 - 501
  • [28] Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
    Li, P
    Nijhawan, D
    Budihardjo, I
    Srinivasula, SM
    Ahmad, M
    Alnemri, ES
    Wang, XD
    [J]. CELL, 1997, 91 (04) : 479 - 489
  • [29] Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M-bovis
    Mahairas, GG
    Sabo, PJ
    Hickey, MJ
    Singh, DC
    Stover, CK
    [J]. JOURNAL OF BACTERIOLOGY, 1996, 178 (05) : 1274 - 1282
  • [30] Mitochondrial permeability transition is a central coordinating event of apoptosis
    Marchetti, P
    Castedo, M
    Susin, SA
    Zamzami, N
    Hirsch, T
    Macho, A
    Haeffner, A
    Hirsch, F
    Geuskens, M
    Kroemer, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) : 1155 - 1160